Company intelligence / Profile preview
Crinos
- Ownership
- Private
- Development stage
- Other
Overview
Crinos is an Italian pharmaceutical company founded in 1944, specializing in the research, development, and commercialization of treatments for cardiovascular and metabolic diseases. The company is historically significant for discovering and developing sulodexide and defibrotide, two complex biological drugs used globally for vascular and hematological conditions. In 1996, Crinos was acquired by Mediolanum Farmaceutici, under which it continues to operate as a prominent brand in the Italian healthcare market. Its current portfolio focuses on vascular health, gastroenterology, and specialized primary care products. The company maintains a strong presence in Italy while its legacy products are distributed internationally through various licensing partnerships.
- Therapeutic areas
- HematologyCardiovascularNephrology
- Modalities
- BiologicSmall molecule
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Crinos.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Crinos.